These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20173695)

  • 1. Pharmacologic mood destabilization: case vignettes.
    Swann AC
    CNS Spectr; 2009 Nov; 14(11 Suppl 11):9-11; discussion 12-4. PubMed ID: 20173695
    [No Abstract]   [Full Text] [Related]  

  • 2. Mania induction associated with atomoxetine.
    Henderson TA
    J Clin Psychopharmacol; 2004 Oct; 24(5):567-8. PubMed ID: 15349024
    [No Abstract]   [Full Text] [Related]  

  • 3. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
    Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
    J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The practice and problem of therapeutic agents for AD/HD].
    Tanaka H; Miyajima T
    No To Hattatsu; 2010 May; 42(3):213-6. PubMed ID: 23858580
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-stimulant trials of adult ADHD.
    Adler LA
    CNS Spectr; 2007 Apr; 12(4 Suppl 6):11-3. PubMed ID: 17717871
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls.
    Daughton JM; Kratochvil CJ
    J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):240-248. PubMed ID: 19242289
    [No Abstract]   [Full Text] [Related]  

  • 7. Lamotrigine-induced mania in adolescents.
    Moor S; Luty S; Joyce P
    Aust N Z J Psychiatry; 2007 Dec; 41(12):1013. PubMed ID: 17999274
    [No Abstract]   [Full Text] [Related]  

  • 8. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract]   [Full Text] [Related]  

  • 9. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders.
    Hah M; Chang K
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):996-1004. PubMed ID: 16379520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomoxetine-associated hemospermia: a case report.
    Raj YP
    J Clin Psychiatry; 2008 Jul; 69(7):1189. PubMed ID: 18687023
    [No Abstract]   [Full Text] [Related]  

  • 11. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
    Jaworowski S; Benarroch F; Gross-Tsur V
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine-induced severe manic switch.
    Desarkar P; Sinha VK
    Aust N Z J Psychiatry; 2006 Aug; 40(8):718. PubMed ID: 16866770
    [No Abstract]   [Full Text] [Related]  

  • 13. The answerable question and a hierarchy of evidence.
    Hamilton J
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):596-600. PubMed ID: 15908843
    [No Abstract]   [Full Text] [Related]  

  • 14. What is the significance of the new warnings about suicide risk with Strattera?
    Miller MC
    Harv Ment Health Lett; 2005 Dec; 22(6):8. PubMed ID: 16437773
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
    Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M
    Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
    McElroy SL; Zarate CA; Cookson J; Suppes T; Huffman RF; Greene P; Ascher J
    J Clin Psychiatry; 2004 Feb; 65(2):204-10. PubMed ID: 15003074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atomoxetine-induced hypomania-like symptoms in a preadolescent patient.
    Guney E; Uneri OS
    J Child Adolesc Psychopharmacol; 2014 Nov; 24(9):530-1. PubMed ID: 24494808
    [No Abstract]   [Full Text] [Related]  

  • 18. Atomoxetine and stimulants in combination for treatment of attention deficit hyperactivity disorder: four case reports.
    Brown TE
    J Child Adolesc Psychopharmacol; 2004; 14(1):129-36. PubMed ID: 15142400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatments and approaches for attention deficit hyperactivity disorder.
    Newcorn JH
    Curr Psychiatry Rep; 2001 Apr; 3(2):87-91. PubMed ID: 11276402
    [No Abstract]   [Full Text] [Related]  

  • 20. Tourette's symptoms provoked by lamotrigine in a bipolar patient.
    Seemüller F; Dehning S; Grunze H; Müller N
    Am J Psychiatry; 2006 Jan; 163(1):159. PubMed ID: 16390908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.